Analyst firms Leerink Partners and Baird reiterated bullish stances and raised price targets for Intuitive Surgical.
4 reports, 1 independent
Updated Aug 10
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst firms Leerink Partners and Baird reiterated bullish stances and raised price targets for Intuitive Surgical.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.Also in this story
- FDA approved Medtronic's Hugo robotic system for urological procedures, marking a major competitive shift in the medical device sector.
- Market sentiment regarding growth rates turned disappointing for companies like Profound Medical on August 1, 2025.
- Medtronic is developing a robotic-assisted surgery system that needs regulatory approval in the US, amidst aggressive trade policy threats.
- Lemaitre, Intuitive Surgical, and Teleflex are identified as companies operating in the surgical equipment segment.
The entities involved
-
Intuitive Surgical
American corporation
Coverage
Newest first; wire copies grouped- Insider MonkeyBaird Lifts PT on Intuitive Surgical (ISRG) to $600 From $590, Keeps an Outperform Rating Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best stocks to invest in for the long term. On July 23,
- Insider MonkeyBaird Raises PT on Intuitive Surgical (ISRG) to $600 From $590, Keeps an Overweight Rating Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best stocks to invest in for beginners. On July 24, Bai